• 专利附录
  • 专利说明
  • 权利要求
  • 类似技术
  • 同族专利
  • 引用文献
  • 法律状态
  • 优先权
    • 专利摘要:
    An implant material for filling bone defects, bone regeneration and bone tissue engineering, an implant comprising the bone material, and methods for making such an implant. The implant material made of a hybrid material according to the invention comprises: a biodegradable polymer P soluble in at least one SI solvent and insoluble in at least one solvent S different from the solvent SI and a bioactive glass based on SiO2 and CaO, containing optionally P2O5 and / or optionally doped with strontium, and is characterized in that it comprises the superposition of a porous part having more than 90% by number, of pores whose largest dimension is greater than or equal to 100 μm, and a dense portion (2, 20, 200, 2000, 20000) having more than 80% by number, of pores whose largest dimension is less than 50 microns. The invention finds application in the field of bone regeneration, particularly in the field of tissue engineering of bone.
    公开号:FR3026309A1
    申请号:FR1459209
    申请日:2014-09-29
    公开日:2016-04-01
    发明作者:Jonathan Claude Alexandre Lao；Edouard Daniel Albert Jallot；Xavier Louis Dieudonne
    申请人:Centre National de la Recherche Scientifique CNRS；Universite Blaise Pascal Clermont Ferrand II；
    IPC主号:
    专利说明:

    [0001] An implant material for filling bone defects, bone regeneration and bone tissue engineering, an implant comprising the bone material, and methods for making such an implant. The global aging of the population and the disorders of the osteo-articular system that accompany it make it necessary to develop high-performance bone replacement materials. 18 billion euros in health care costs are spent each year in France for diseases of the osteo-articular and dental system, musculoskeletal disorders are the most common occupational pathologies in industrialized countries, while osteoporosis develops in elderly patients; These facts outline the contours of a major societal and economic issue and explain the growing demand for biomaterials, implants with increased lifespan capable of filling bone loss. Since the use of grafts is limited, and materials of animal origin may pose problems of biocompatibility or risks of infection, research efforts aim to develop synthetic biomaterials capable of promoting bone regeneration. In this case we speak of bioactive implants: the implanted material is not simply intended to passively fill a bone loss while remaining as inert as possible, but on the contrary it must stimulate and participate actively in the bone regeneration mechanism. This is particularly important in the case of large bone defects, for which the self - healing mechanism no longer works. Currently, the main bioactive materials used as bone substitutes are bioactive "ceramics", such as calcium phosphates, and bioactive glasses, also called "bioverres".
    [0002] The first bioactive ceramics were developed by LL Hench (Hench Li et al., J. Biomed, Mater Res 1971,2,117-141, LL Hench et al., J. Biomed, Mater Res 1973). 7, 25-42). The first bioactive glasses were prepared from SiO2, P205, CaO and Na2O. The oxides of silicon and phosphorus are network foimators that participate in the cohesion of the glass network. Alkaline and alkaline earth metals such as sodium and calcium do not have this capacity and modify the glass network by introducing chain breaks that are responsible for the low melting temperature of these glasses associated with an increased structural disorder. . Their presence results in a greater reactivity of bioactive glasses, especially through their corrosion in an aqueous environment. This reactivity allows the formation of hydroxyapatite in a physiological medium and thus promotes bone reconstruction. The bioglass that has been studied the most is a soda-silico-phospho-calcic glass called Bioglass® or Bioverre de Hench. Its base composition is 45% SiO 2 - 24.5% CaO - 24.5% Na 2 O - 6% P 2 O 5, in weight relative to the total mass of the composition. The remarkable bioactive properties of this material are well established. Bioglass® remains at the moment one of the most interesting bioactive materials (inducing a specific cell response). Numerous developments have been made in the field of bioactive glasses since their discovery (M. Vallet-Regi et al., Eur J. Inorg Chem, 2003, 1029-1042), such as the incorporation of different atoms or the like. incorporation of active ingredients. The compositions of the bioactive glasses have been optimized to promote the proliferation of osteoblasts and the formation of bone tissue (WO 02/04606). The incorporation of silver has been proposed in particular for imparting antibacterial properties to bioactive glasses (WO 00/76486). The application WO 2009/027594 describes a bioactive glass in which the strontium is introduced in amounts of between 0.1 and 10% of the total weight of the bioactive glass. These bioactive materials have the characteristic of being both biocompatible, able to bind spontaneously to bone tissue, to promote the adhesion of bone cells and finally to be bioabsorbable, being gradually replaced by neoformed bone tissue that bone regrowth advances. For the filling of large bone defects, the implants must have, in addition to the preceding characteristics, a specific morphology: this one is inspired by the trabecular bone, namely a highly porous structure consisting of a three-dimensional network of interconnected macropores. several hundred microns. Indeed, in the case of large bone defects, the cells of the bone need an extracellular "support" matrix capable of guiding and stimulating adhesion, proliferation, cellular differentiation, while being compatible with the process of vascularization and tissue invasion.
    [0003] Such a macroporous structure is also required for the new applications envisaged in tissue engineering of the bone: it is, from cells taken from the patient, to manufacture in the laboratory new bone tissue that can be reimplanted a posteriori in the patient. To be optimally conducted, this tissue culture must again be based on porous three-dimensional supports allowing good cell adhesion, differentiation in mature cells as well as tissue production and in particular biomineralization. Joaquin Rodenas-Rochina et al. describe in "Comparative study of PCL-HAp and PCL-composite bioglass seaffolds for bone tissue engineering" J. Mater Sei: Mater Med (2013) 24: 1293.-1308, implants made of a polymeric composite bioverre or polymer-hydroxyapatite composite material having such a macroporous structure. However, implants having a mixed structure having both a dense region and a macroporous region are required in maxillofacial surgery and orthopedics. For some applications, the thickness required for the dense part of the implant can be substantial, up to several mm thick. At present, only autograft or allograft can meet this need. These are the only sources of mixed bones with sufficiently large cortical parts. If autograft is the gold standard, the low sample volume possible on the patient himself and the risk of donor site morbidity are serious limitations; in addition, this requires the patient additional surgery. Regarding the allograft, it consists here of a massive bone sample on cadaveric donors which is complex; the quantities of available grafts remain very limited because the massive bones are poorly harvested tissues, their morphological characteristics must correspond to those of the patient, and the regulations concerning their distribution are binding. The development of synthetic substitutes is a solution to these problems. In dental surgery, various techniques may also require implants with a porous / dense composite structure. Among them, the technique of guided bone regeneration uses physical barriers to prevent the colonization of bone tissue by the connective and epithelial soft tissues, thus allowing only cells with osteogenic power to invade the scar area. At present, resorbable or non-resorbable synthetic membranes are used to play this role of barrier, or else to limit the resorption of a bone graft. Non-resorbable membranes PTFE type have the disadvantage of having to be fixed by screws and a second intervention to remove them, as well as the risks of exposure and infection of the membrane. The resorbable membranes are of the collagenous or synthetic type and although they reduce postoperative complications, they always require a filling material supporting the membrane: see Hadi Antoun, Michel Karouni, Bouchra Sojos, Guided bone regeneration: results, limits and perspectives, OdontoStatistics News 261: 11-21, 2013.
    [0004] In comparison, a single implant with a mixed porous / dense structure would have the advantage of a true continuity between the porous part, intended for filling, and the dense part, acting as a barrier; in addition to being resorbable, additional properties can be imparted to the dense part, such as bioactivity. In summary, although many materials and formulations have been developed for filling bone loss, none fully meets the specifications describing the ideal implant, namely: - to be biocompatible; - be bioactive: spontaneously induce the formation of a strong interfacial link with the bone tissues, promote adhesion and cellular activity; - be bioabsorbable; having an adequate morphology based on a three-dimensional matrix of interconnected macropores, this three-dimensional matrix of interconnected macropores being associated with a three-dimensional matrix having only a very small number of pores; - have good mechanical strength; - Be derived from a manufacturing process for easy shaping and flexible enough to adapt to many fault geometries and to obtain two parts: a dense part and a porous part.
    [0005] By adequate morphology based on a three-dimensional matrix of interconnected macropores, it is meant that the size, shape and distribution of the pores as well as the size of the interconnections between these pores must be controlled. By associating a three-dimensional matrix of interconnected macropores with a matrix having a small number of pores, is meant a matrix consisting, in all cases, of the same hybrid material, and one of whose parts comprises a three-dimensional network of interconnected macropores and the other part, a part is dense. Thus, it is an object of the invention to provide a material which perfectly meets all these criteria and which can be manufactured by methods which allow the realization of architectures comprising an association of a porous part and a dense part composed of an organic part and an inorganic part, in the form of a hybrid material. For this purpose, the invention provides an implant material for filling bone defects, bone regeneration and tissue engineering of bone, characterized in that it comprises a matrix of a hybrid material comprising: - a biodegradable polymer P soluble in at least one Si solvent and insoluble in at least one solvent S different from the solvent S1 and a bioactive glass based on 5iO2 and CaO, optionally containing P205 and / or optionally doped with strontium, characterized in that comprises the superposition of: - a porous part having more than 90% by number, of pores whose largest dimension is greater than or equal to 100 μm, and - a dense part having more than 80% in number, of pores whose most large dimension is less than 50 m. Preferably, the volume ratio of dense part to volume of porous part is between 10/90 and 90/10. In a first mode of implementation, the pores of the porous part all have the same shape and the same dimensions within plus or minus 10%. By same dimensions, it is meant that the pore sizes do not vary more or less than 10% relative to each other.
    [0006] In a second embodiment, the porous portion has pores whose largest dimension decreases from the base of the implant to the dense portion. In a third embodiment, the porous portion has pores whose largest dimension increases from the base of the implant to the dense portion. In a first embodiment, the porous part and the dense part are in planar superposition. In a second embodiment, the porous part and the dense part are in concentric superposition. The pores of the porous portion may have a spherical shape or polygons, preferably in the form of squares.
    [0007] The invention also proposes a method for manufacturing an implant material according to the invention having spherical pores, characterized in that it comprises the following steps: a) selection of the alkoxy precursors of a bioactive glass M based on of SiO 2 and CaO, optionally containing P 2 O 5 and / or optionally doped with strontium, b) selecting a biodegradable polymer P which is soluble in at least one Si solvent and insoluble in at least one solvent S different from the solvent Si, c) selection of microspheres of a porogenic agent A having diameters and sizes corresponding to the desired diameters and sizes of the pores in the material constituting the implant to be produced, this porogenic agent A being: in a polymer that is insoluble in the at least one solvent S1 and soluble in the at least one solvent S, the at least one solvent S in which the material of the biodegradable polymer P is insoluble and the at least one solvent S in which the material of the agen The porogenic agent A is soluble being identical, d) introducing the microspheres of the porogenic agent A into a mold having the shape and size desired for the implant, these microspheres forming a compact stack corresponding to the size and shape of the pores to obtain for the porous part of the implant material, and representing between 5% and 50% by volume, relative to the total volume of the pore-forming agent mixture A-biodegradable polymer P-alkoxy precursors of the bioactive glass M, e) introduction of the polymer biodegradable P in the alkoxy precursors of bioactive glass M, f) introduction of the mixture obtained in step e) into the mold, g) gelling of the mixture contained in the mold after step f), h) demolding of the mixture obtained in step g), i) removal of the microspheres of porogenic agent A by washing with the solvent S. The invention also proposes a method of manufacturing an implant material according to the invention in which the pores can have any desired shape, including that of polygons, characterized in that it comprises the following steps: a) selection of alkoxide precursors of a bioactive glass M based on SiO 2 and CaO, optionally containing P205 and / or optionally doped with strontium, b) selection of a biodegradable polymer P which is soluble in at least one Si solvent and insoluble in at least one solvent S different from the solvent Si, e) manufacture, by 3D printing, of a preform, into an insoluble polymer in the at least one solvent S1 and soluble in the at least one solvent S, this preform being the reverse replica in terms of final shape and size desired for the pores in the porous part of the final implant and representing between 5 and 50 % by volume of the total volume of the biodegradable preform-bi-polymer precursor biodegradable mixture of the bioactive glass M, d) introduction of the preform into a mold having the desired shape and size of the final implant, e) introduced the biodegradable polymer P in the alkoxy precursors of the bioactive glass M, t) introducing the mixture obtained in step e) into the mold, g) gelling the mixture contained in the mold after step f), h) demolding the mixture obtained in step g), i) removal of the preform by washing with the solvent S.
    [0008] In these two processes steps e) and / or f) can be implemented before step d). But, steps d), e) and f) can also be implemented simultaneously. To obtain an implant material in which the porous portion and the dense portion of the implant material are planarly superimposed, in step d), the microsphere compact stack or preform is placed to touch the walls. side of the mold, leaving a free space above the stack of microspheres or preform. To obtain an implant material in which the porous portion and the dense portion of the implant material are concentrically superimposed, in step d), the compact stack of microspheres or the preform are placed in the center of the mold leaving a free space between the compact stack of microspheres or the sidewalls of the preform and the sidewalls of the mold. Preferably, the biodegradable polymer P is a biodegradable polymer that is soluble in at least one solvent S1 and insoluble in at least one solvent S, chosen from: - bioresorbable polysaccharides, preferably chosen from dextran, hyaluronic acid, agar, chitosan, alginic acid, sodium or potassium alginate, galactomannan, carrageenan, pectin, bioresorbable polyesters, preferably polyvinyl alcohol or poly (lactic acid), biodegradable synthetic polymers, preferably a polyethylene glycol, or poly (caprolactone), - proteins, preferably gelatin or collagen, and the material of the blowing agent or preform is a material selected from biodegradable polymers insoluble in the at least one solvent S1 and soluble in the at least one solvent S, preferably chosen from C1-C4 alkyl polymethacrylates, preferably polymethyl methacrylate; methyl or butyl polymethacrylate, polyurethane, polyglycolic acid, various forms of polylactic acid, copolymers of lactic acid-coglycolic acid, polycaprolactone, polypropylene fumarate, paraffin and naphthalene, or acrylonitrile butadiene styrene (ABS), the material of the blowing agent A or the preform being different from the biodegradable polymer P.
    [0009] Also preferably, the biodegradable polymer weight ratio P / bioactive glass M is between 20/80 and 80/20 inclusive. Still preferably, the bioactive glass M is a glass based on SiO 2 and CaO, the biodegradable polymer P is gelatin, the material of the preform is ABS and the solvent S is acetone.
    [0010] When the stack of microspheres is used to create the pores, preferably the bioactive glass M is a glass based on SiO 2 and CaO, the biodegradable polymer P is gelatin, the porogen material A is polymethyl methacrylate and the Solvent S is acetone. The methods of the invention may further comprise, in step f), a step of introducing a coupling agent, preferably an organoalkoxysilane compound, more preferably 3-glyeidoxypropyltrimethoxysilane (GPTMS), still more preferably 3-glycidoxypropyltriethoxysilane (OPTES). The invention finally proposes an implant made of a hybrid material for filling bone defects, bone regeneration and tissue engineering of the bone, characterized in that it comprises an implant material according to the invention or obtained by one or the other of the methods of the invention. The invention will be better understood and other features and advantages thereof will appear more clearly on reading the explanatory description which follows and which is made with reference to the appended figures in which: - Figure 1 is a schematic representation of an implant according to the invention, wherein the porous part has pores all of the same size and the dense part is superimposed in a planar structure on the porous part; - Figure 2 is a schematic representation of an implant according to the in which the pores of the porous portion have a gradient of decreasing pore size from the base of the implant to the dense portion of the implant which is superimposed in a planar configuration on the porous portion of the implant; FIG. 3a is a photograph of an implant according to the invention in which the porous part and the dense part form a planar superposition structure; FIG. 3b is a photogra FIG. 3c shows a photograph taken at an x30 magnification of the implant shown in FIG. 3b, at a magnification of x30 of the implant shown in FIG. FIG. 4 represents a flowchart of the first process for manufacturing an implant made of a hybrid material (based on bioactive glass and gelatin) according to the invention; FIG. schematically represents a prefollne, obtained by 3D printing, used in the second process for manufacturing an implant made of a hybrid material according to the invention; - FIG. 5b is a photograph of a section of the implant according to the invention, in which the porous portion and the dense portion are superimposed in a planar configuration, - Figure 5e shows a photograph taken with a scanning electron microscope at x30 magnification of the implant shown in Figure 5b at the interface. Porous part / dense part, FIG. 6 shows the evolution curves as a function of time of the composition (in ppm) of the physiological medium brought into contact with class I hybrid implants in bioactive glass / gelatin (50% ( SiO 2 -Ca0) / 50% gelatin) according to the invention, FIG. 7 shows the evolution curve as a function of time of the concentration (in ppm) of silicon and proteins of the physiological medium (SBF) brought into contact with class I and class II hybrid implants in bioactive glass / gelatin (30% (SiO2-CaO) / 70% gelatin) according to the invention; FIG. 8 shows the evolution curves as a function of time of the concentration; in calcium and phosphorus (in ppm) of the physiological medium (SBF) brought into contact with class I and class II hybrid implants in bioactive glass / gelatin (30% (SiO 2-CaO) / 70% gelatin) according to the invention FIG. 9a shows a photograph of a section of an implant in a class I hybrid material consisting of 30% bioglass / 70% gelatin B of which one part is dense and the other part is porous in planar superposition, obtained in Example 1; - Figure 9b shows a photograph taken under a scanning electron microscope at a magnification of x20 of a section of the implant. hybrid shown in Figure 9a, - Figure 10a shows a photograph of a section of an implant in a class I hybrid material consisting of 30% bioglass / 70% gelatin B, one part is dense and the other part is porous concentric superposition, obtained in Example 2, - Figure 10b shows a scanning electron microscope view at a magnification of x20 of a section of the implant in a hybrid material shown in Figure 10a, - the FIG. 1 shows a photograph of a section of an implant made of a class II hybrid material consisting of 30% bioglass / 70% gelatin B, part of which is dense and the other part is porous in planar superposition, obtained in example 3, 10 - FIG. a scanning electron microscope at a magnification of x20 of a section of the implant shown in FIG. 11a; FIG. 12a shows a photograph of a section of an implant made of a class I hybrid material consisting of 30% of bioglass / 70% of poly-DL-lactic acid (PDLLA), one part of which is dense and the other part is porous in planar superposition, obtained in Example 4, - Figure 12b shows a photograph taken using a scanning electron microscope at x20 magnification of a section of the implant shown in FIG. 12a; FIG. 13a shows a photograph of a section of an implant made of a class II hybrid material consisting of 30% of bioglass / 70% polycaprolactone (PCL) 20 of which one part is dense and the other part is porous in planar superposition, obtained in Example 5; - Figure 13b shows a photograph taken under a scanning electron microscope at a magnification of x20 of a cut of the implant into a material In FIG. 14a, FIG. 14a shows a photograph of a section of an implant made of a class I hybrid material consisting of 30% bioglass / 70% PDLLA with a so-called random porosity, obtained at the same time. Example 6 - Figure 14b shows a x20 magnification scanning electron micrograph of a section of the porous portion of the implant in a hybrid material shown in Figure 14a; Figure 15a shows a photograph of a section of an implant in a class II hybrid material consisting of 30% bioglass / 70% PCL with a so-called random porosity, obtained in example 7, - figure 15b shows a photograph taken under a microscope At a x20 magnification scan of a section of the porous portion of the implant into a hybrid material shown in FIG. 15a, FIG. 16a shows a photograph of a section of an implant in a hybrid material of FIG. class I consisting of 30% bioverage / 70% P CL with increasing pore size from the base of the implant to the top of the implant, obtained in Example 9, and - Figure 16b shows a photograph taken under a scanning electron microscope at a magnification of x20 of a section of the implant in a hybrid material shown in Figure 16a. In the foregoing and the following, the following terms have the following meanings: - "porous part": part of the implant material in which more than 90% by number of pores have their largest dimension greater than or equal to 100 - "dense part": part of the implant material in which more than 80% by number of pores have their largest dimension less than 50 microns, - "interconnection (s) between pores": opening (s) ) allowing the passage from one pore to the other, - "aqueous medium": any liquid medium containing water, or water alone, - "biodegradable": degradable in a physiological liquid, for example a buffered saline solution (SBF), - "bioabsorbable": removable in a physiological medium containing biological cells, - "spherical pore" or "sphere": pore or sphere whose ratio of the smallest diameter to the largest diameter is 0.9 ± 0.1, 25 - "compact stack of microspheres of porogen A" emp wherein at least 70% by number, preferably more than 95% by number of microspheres are in contact with one another, and remain in contact with one another when the agent mixture Pore-forming A and biodegradable polymer hybrid P-bioactive glass M-are in the mold, and when the stack of microspheres is covered and infiltrated with the hybrid mixture bioactive glass M-biodegradable polymer P. It is possible to obtain such a compact stack of microspheres of porogenic agent A by centrifugation of the microsphere mixture of porogenic agent A and biodegradable polymer hybrid P-bioactive glass M or else by applying a negative pressure (vacuum) or a positive pressure (greater than atmospheric pressure) on the agent microsphere mixture porogen A and biologically-degradable polymer hybrid P-bioactive glass M introduced into the mold, before and during the gelation of this mixture. Implant material for filling bone defects, bone regeneration and tissue engineering of the bone will be described in connection with Figures 1, 2, 3a) - 3c), 5b) and 5c). As seen in these figures, the implant material of the invention comprises a matrix comprising a porous portion, denoted 1, 10, 100, 1000, 10000 in the figures, and a dense portion, denoted 2, 20, 200 , 2000, 20000 in the figures, called dense, that is to say in which the pores have a size less than 50 microns. The porous portion and the dense portion are superimposed, one over the other, or one around the other, without any added material or layer. The final material one piece. The matrix of the implant material of the invention consists of an organic phase and an inorganic phase. The inorganic phase is a bioactive glass M. Bioactive ceramics and bioactive glasses are well known to those skilled in the art and are described in particular in L. L. Hench et al., J. Biomed. Mater. Res. 1971, 2, 117-141; L. L. Hench et al., J. Biorned. Mater. Res. 1973, 7, 25-42 for bioactive ceramics and in M. Vallet-Regi et al., Eur. J. Inorg. Chem. 2003, 1029-1042 and WO 02/04606, WO 00/76486 and WO 2009/027594, in particular. In the invention, only a bioactive glass is used. The organic part of the implant material of the invention is a biodegradable polymer P soluble in at least one Si solvent and insoluble in at least one solvent S.
    [0011] These solvents may be water, an aqueous medium or an organic solvent. Preferably, the biodegradable polymer P is chosen from: - bioresorbable polysaccharides, preferably chosen from dextran, hyaluronic acid, agar, chitosan, alginic acid, sodium or potassium alginate, galactomannan, carrageenan, pectin, - bioabsorbable polyesters, preferably polyvinyl alcohol or poly (lactic acid), - biodegradable synthetic polymers, preferably a polyethylene glycol, or poly (caprolactone), and - proteins preferably gelatin or collagen.
    [0012] The matrix of the implant material of the invention consists of the bioactive glass M and the biodegradable polymer P which form a hybrid material, that is to say forming a single phase. The hybrid material used in the invention is obtained by a process which comprises the formation of a sol containing all the alkoxy precursors of the bioaqueous glass, the addition of the biodegradable polymer P in this sol and the gelling of the solution thus obtained by a succession of polymerization reactions (sol-gel polymerization of the inorganic phase) (condensation of the alkoxides). This gives a hybrid mixture intimately associating the mineral phase and the organic phase.
    [0013] The porous portion 1, 10, 100, 1000, 10000 of the implant of the invention may have pores 3 all having the same size, that is to say pores whose dimensions do not exhibit a variation of more or at least 10% relative to each other as shown in FIG. 1 or having decreasing pore sizes from the bottom of the porous portion to the top of the porous portion, as shown in FIG. 2, or conversely, But, the pore size can also be alternated (a row of larger diameter pores than the next row etc ...). On or around this portion 1, 10, 100, 1000, 10000 porous, is superimposed in direct connection a dense portion 2, 20, 200, 2000, 20000 consisting of the same hybrid material as the porous portion 1, 10, 100 , 1000, 10000 but this time without porosity created. Also, as seen in Figures 1, 2, 3a, 3b, 3c and 5b and 5c, the part 2, 20, 200, 2000 can be superimposed in a planar configuration above the porous part 1, 10, 100, 1000. It can also be, as shown in FIGS. 10a and 10b, where it is denoted 20000, placed around the porous portion marked 10000, forming a concentric configuration. A first method of manufacturing the implant of the invention is a process using a porogenic agent A which consists of microspheres in a polymer soluble in at least one solvent S in which the biodegradable polymer P is itself not soluble. Thus, the method of the invention consists in stacking microspheres of porogenic agent A in a polymer material, different from the biodegradable polymer P, in a mold having the angle and the size corresponding to the geometry of the bone defect to be filled. or defect where bone regeneration is desired.
    [0014] These microspheres of porogenic agent A finally make it possible to obtain pores whose size and distribution will correspond in negative to the stack of microspheres of porogenic agent A initially produced. This stack of microspheres of porogenic agents makes it possible to obtain the porous part 1, 10, 100, 10000 of the implant material. Indeed, the material intended to constitute the matrix of the implant material of the invention will then be infiltrated into the stack of microspheres beads of porogenic agents A and also, above or around this stack, then then solidified to be demolded without changing the shape and size of the stack of the desired implant. The blowing agent A will then be eliminated, allowing the implant material of the invention formed by the superposition of a controlled porosity part to be obtained, and a dense part in which the pores have their largest dimension less than 50 micrometers. Cc: n = 1e it is seen, this method uses no heat treatment at high temperature to sinter the bioactive glass M, the only necessary temperature being the evaporation temperature of the solvent S used. Figure 4 shows a flowchart of this manufacturing process. As seen in Figure 4, in a first step the pore-forming agent is placed in a suitably shaped container, corresponding to the geometry of the bone defect to be filled. The blowing agent is placed in a stack of spheres made of a polymeric material.
    [0015] The blowing agent must imperatively be removed without heat treatment in order to preserve the organic part of the hybrid material to be developed. It will therefore be chosen from the following list: C1-C4 alkyl polymethacrylates, for example: polymethyl methacrylate or butyl polymethacrylate, polyurethane, polyglycolic acid, the various forms of polylactic acid, copolymers lactic acid-coglycolic acid, polycaprolactone, polypropylene fumarate, paraffin and naphthalene, acrylonitrile butadiene styrene (ABS). PMMA microspheres will preferably be used as the blowing agent.
    [0016] One of the advantages of PMMA is that it can be easily dissolved by many solvents. On the other hand, in the case where PMMA residues are not removed, the good biocompatibility of PMMA with human tissues is a guarantee that the implant will not present any risk of cytotoxicity.
    [0017] In order to control the porosity, and possibly to organize it, it is advantageous to use spherical particles, namely PMMA beads. Their diameter can be chosen between a hundred to several hundred microns, depending on the applications. The porosity of the material which will finally be obtained can be controlled according to three points.
    [0018] First, the diameter of the pores that will be obtained depends directly on the diameter of the initial porogenic particles. It is therefore sufficient to adjust the particle size of the initial PMMA beads to obtain very simply the desired porosity. Secondly, the size of the interconnections between pores depends directly on the size of the contact zone between the polymer beads in the initial stack. The size of this contact zone may be modified by fusing the initial polymer particles together, by means of a solvent, or by a preliminary heat treatment. Thirdly, the initial organization of the porogen balls, the largest dimension of which is between 100 μm and 900 μm, will be either random or stratified by size of beads, but always so as to have a compact stack of beads leaving sufficient space in the mold to allow filling with a surplus of hybrid material under foime soil to obtain a dense portion for 1 implant. This initial organization of the beads may also be a compact stack of pore forming balls A, these balls having all the same shape and the same dimensions. By surplus hybrid soil is meant that the amount of hybrid soil introduced into the mold must be greater than the volume left vacant by the pore-forming agent balls (including the interstitial space accessible between these beads). When this surplus is placed around the stack of balls, in which case the stack of balls is placed in the center of the mold to allow the hybrid surplus intended to form the dense part to be placed between the side walls of the mold and the walls. side of the stack of beads, one obtains a concentric superposition of the porous part and the dense part of the implant material. When this surplus is placed above the porous part, in which case the stack of beads will be placed at the bottom of the mold with its side walls in contact with the side walls of the mold, leaving room for the surplus of hybrid soil above of the stack of balls, an implant material is obtained in which the porous part and the dense part are in planar superposition. In a second step, an organic / inorganic framework composed of a biodegradable polymer phase and a bioactive inorganic phase infiltrates the pore-forming polymer structure; the polymer involved in the hybrid matrix, which is mixed with the bioactive glass must have all the characteristics of biocompatibility, bioresorbability, and can be easily shaped without the intervention of products that can leave cytotoxic residues. This polymer will be chosen from the following list: bioabsorbable polysaccharides, for example: dextran, hyaluronic acid, agar, chitosan, alginic acid, sodium or potassium alginate, galactomarman, carrageenan, pectin, bioabsorbable polyesters, for example: polyvinyl alcohol (PVA) or poly (lactic acid) (PLA), - synthetic biodegradable polymers, for example: polyethylene glycol (PEG) or poly (caprolactone) ) (PCL), proteins, for example: gelatin or collagen. In one embodiment of the invention, the choice of the biopolymer has been on gelatin. Indeed, gelatin is a natural bio-polymer, biodegradable, biocompatible, cheap and easily available. Gelatin is moreover derived from collagen naturally present in the bones. It is also used in the context of clinical applications (dressings, adhesives, encapsulation of pharmaceutical substances). The inorganic part of the hybrid matrix consists of a bioactive glass, because of i) their great capacity to induce mineralization, ii) the possibility of shaping their textural and morphological properties (porosity, size, and therefore specific surface area) at the nanoscale, iii) the broad range of bioactive compositions that can be formulated, for example by adding anti-inflammatory or osteoinductive elements, iv) finally the combination of their bioactivity and bioresorbability properties which make them the most promising biomaterials for bone regeneration, especially compared to calcium phosphates, which are generally either less bioactive or less absorbable. According to the invention, the organic / inorganic framework is produced so as to obtain a hybrid matrix. The hybrid matrix is obtained by integrating the polymer upstream, from the process of synthesis of bioactive glasses, which is based on the sol-gel process.
    [0019] Briefly, during the sol-gel process a solution containing all the chemical precursors of the active bio-glass is made to gel by a succession of polymerization reactions; in our case, the biocompatible polymer (for example gelatin) is added before gelation of the soil, so as to obtain a hybrid mixture intimately associating the mineral and organic species. The hybrid mixture is thus distinguished from a composite mixture by an intimate entanglement between the two organic and inorganic phases, these two phases being indistinguishable (except at the molecular level) in the case of a hybrid mixture. This is typically the case when the size domains of the organic and inorganic phases are less than a few tens of nanometers. For the realization of hybrids, a major difficulty is that heat treatments at high and medium temperatures (> 150 ° C) are to be avoided; however, in the usual processes these heat treatments are essential to obtain a homogeneous glassy network. The invention describes here a new synthetic route conducted at moderate temperature (<60 ° C), close to ambient. In particular, the use of an alkoxide precursor for calcium allows the incorporation of this species into the inorganic phase without theicin treatment. This specific method is described in FIG. 4, using in this example a stack of PMMA beads as porogenic architecture. Once foil and before total gelation, the hybrid mixture is poured onto the pore-forming structure. In addition, it may be advantageous to add a coupling agent to the mixture, such as an organo-alkoxysilane; for example, it can be simply added to the previously dissolved biocompatible polymer. The role of the coupling agent is to functionalize the biocompatible polymer, in order to allow the establishment of covalent bonds with the inorganic phase (silicate network of bioactive glass). A true organo-mineral copolymer is thus obtained. The interest is to be able to control the degradability of the hybrid implant as well as its mechanical strength, by simply acting on the number of chemical bonds created between the organic and inorganic phases, this number of chemical bonds created depending on the quantity of the hybrid implant. coupling agent introduced. An example of a coupling agent successfully used by the inventors is GPTMS (3-glycidoxypropyltrimethoxysilane), which is soluble for example in an aqueous gelatin solution.
    [0020] In a third step, the container and its mixture undergo a gelling operation for several hours ensuring the "setting" of the mixture. This operation can be carried out at a moderate temperature close to ambient (<60 ° C) so as not to degrade the organic part of the hybrid.
    [0021] In a fourth step, the polymer architecture of porogenic material is removed by dissolving in a suitable solvent. In the examples described in FIG. 4, the PMMA beads are removed by washing with acetone. The choice of acetone has several interests. First of all the PMMA beads are easily dissolved in acetone; gelatin is insoluble in acetone; acetone further allows to continue if necessary the dehydration of gelatin; finally it is a very common, relatively economical, particularly available, recyclable, solvent that does not present a serious risk of toxicity. After several washing steps, the initial pore imprint is completely removed and the final bioactive glass / biocompatible polymer hybrid material is obtained as a macro-porous block in whole or in part. Its degradability in living medium and its mechanical strength can in addition be easily adjusted by crosslinking the biocompatible polymer during a final immersion step in a solution of a crosslinking agent such as for example genipin, carbodiimide, glutaraldehyde, Formaldehyde. The structures obtained can be washed without any damage in ethanol baths, in order to eliminate any undesirable residues (chloride, acetone, etc.). A second method for manufacturing the implant according to the invention is based on the use of a prefoime, made of a polymeric material, produced by 3D printing, as a porogenic agent. The advantage of this method is to be able to adjust the porosity (shapes and sizes of the pores) in a way. As shown in FIG. 5a, a preform of a polymeric material selected from the same materials as previously mentioned as the materials of the blowing agent A, more preferably a square mesh acrylonitrile butadiene styrene (ABS) preform is used instead. PMMA beads, in the flowchart shown in FIG. 4. Thus, after the elimination of the preform (9), the inverse replica of this preform is easily obtained, in this case a highly porous hybrid matrix with pores of perfectly controlled periodically spaced waist, and regular size walls. In the same way as above, a dense part is obtained in the implant when the container is filled not only at the preform (9) but also above this preform. An implant material is thus obtained as shown in FIG. 5b having a planar structure.
    [0022] The container may also be filled not only at the preform (9) but with the preform not touching the side walls of the container and the space between the side walls of the container being filled with hybrid material alone, without pore-forming agent.
    [0023] An implant material having a concentric structure is then obtained. The preform when in ABS, can be removed by washing in acetone. It will be understood immediately that the material of the microspheres of the blowing agent A and that of the preform (9) must be different from the biodegradable polymer P used to obtain the hybrid material of the implant of the invention. Also, the preform (9) can itself constitute the container. In order to better understand the invention, several embodiments will now be described by way of purely illustrative and nonlimiting examples.
    [0024] Example I. Manufacture of an Implant Material According to the Invention with a Matrix of Hybrid Material with a Dense Part and a Porous Part in Planar Superposition The compact stacking step of the polymethyl methacrylate porous agent microspheres was initiated in a mold having the desired geometry for the implant and with a volume greater than the size of the implant. The compact stack of blowing agent pellets represented 40% by volume, based on the total volume of the porogenic agent mixture A-biodegradable polymer P-precursor alkoxides of the bioactive glass M. The material of the blowing agent A was the polymethacrylate of methyl. The spheres had a diameter of between 400 and 600 μm.
    [0025] In a second step, the hybrid mixture was poured into the mold containing the stack of beads. The volume of hybrid mixture is strictly greater than the volume left by the interstices between the balls. The volume is adjusted to fill the entire useful volume of the mold. Thus, the volume of hybrid soil is equal to the difference between the useful volume of the mold and the volume occupied by the balls.
    [0026] Centrifugation or pressure infiltration or vacuum infiltration may be used to help the hybrid mixture fill the interstices between the poly (methyl methacrylate) microspheres. A cap, whose surface is flat, is placed in contact with the ground with the help of a slight pressure in order to obtain a flat surface on the implant.
    [0027] The hybrid material was obtained by a sol-gel process. In this process, a sol containing all the alkoxy precursors of the bioactive glass is made to gel by a succession of polymerization reactions. The alkoxide precursors were in such quantities that the composition of the bioactive glass was 75% SiO 2 and 25% CaO, by weight, relative to the total mass of the bioactive glass finally obtained. In the case of the present example, the gelatin (the biodegradable polymer P) was added before gelation of the soil, so as to obtain a hybrid mixture. For the production of hybrid material, a major difficulty is that heat treatments at high and medium temperatures, that is to say above 150 ° C are to be avoided. However, in the processes described in the prior art and in particular in Lin, S. et al., "Nanostructure evolution and calcium distribution in sol-gel derived bioactive glass". Journal of Materials Chemistry 2009, 19, (9), 1276-1282, these heat treatments are essential for obtaining a homogeneous glassy network, especially for the incorporation of calcium into the silicate network. The use of an alkoxide precursor for calcium allows the incorporation of calcium into the inorganic phase without heat treatment. However, the very high reactivity of calcium alkoxides with respect to hydrolysis / condensation reactions in the presence of water means that the soil obtained is very unstable, the sol-gel polymerization taking place extremely rapidly, which has made it impossible to until now its manipulation to achieve a porous implant and also did not allow a good incorporation of calcium in the silicate network. Thus, the inventors have found that by minimizing the introduction of water into the soil and using an alkoxide precursor different from that used in the literature (Ramila A. et al., Synthesis routes for bioactive sol-gel glasses: alkoxides versus nitrates. "Chemistry of Materials 2002, 14, (12), 542-548) (i.e. calcium methoxyetboxy), it is possible to greatly increase the stability of the soil. The hydrolysis / condensation reactions are then slow enough to allow a homogeneous incorporation of calcium into the silicate network, while remaining fast enough to allow the polymerization of the inorganic phase. In the example, the alkoxide precursors of silicon and calcium are mixed together in a slightly acidified alcoholic solution. Preferably, the alkoxide precursors are tetraethoxysilane and calcium ethoxide. Then the previously dissolved gelatin is added to this mixture to obtain a hybrid soil. The only water supply is through the acid and the gelatin solution: this is sufficient to allow the hydrolysis / condensation reactions while limiting them strongly so as to have a stable and manipulable soil between a few minutes and a few hours depending on the proportions of the reagents.
    [0028] During the preparation of the hybrid mixture, it may be advantageous to add a coupling agent, such as an organo-alkoxysilane, to the mixture. Indeed, two classes of hybrid organic-inorganic implants can be made, depending on the nature of the interface that combines the organic components (biocompatible polymer) and inorganic (bioactive glass). Class I corresponds to hybrid systems in which the two components interact by weak bonds (hydrogen bonds, Van der Waals, or electrostatic bonds). In Class II, on the other hand, the organic-inorganic components are strongly bound by covalent or ionocovalent bonds. This can be achieved by means of a coupling agent. For example, the coupling agent can be simply added to the aqueous solution of the biodegradable polymer P, here gelatin. The role of the coupling agent is to functionalize gelatin, in order to allow the establishment of covalent bonds with the inorganic phase (silicate network of bioactive glass). In the case of a composite mixture, the coupling makes it possible to obtain bioactive glass particles that are surface-bound to gelatin. In the case of a hybrid mixture, a true organo-mineral copolymer (class II hybrid) is obtained. The interest is to be able to control degradability of the composite or hybrid implant as well as its mechanical strength, by simply acting on the number of chemical bonds created between organic and inorganic phases, this number of chemical bonds created being linked to the amount of coupling agent introduced. An example of a coupling agent successfully used in the invention is GPTMS (3-glycidoxypropyltrimethoxysilane), which is soluble in an aqueous gelatin solution. An implant material consisting of 70% by weight of gelatin and 30% by mass of bioactive glass was obtained with a dense part representing 25% of the volume of the implant and a porous part representing 75% of the volume of the implant. implant.
    [0029] This material is shown in FIGS. 9a and 9b. As can be seen in Figure 9a, the material obtained has a size of 2 cm x 0.5 cm very regular and compact. As seen in Figure 9b, this implant consists of a dense portion and a porous portion planar superposition.
    [0030] Exempt 2: Manufacture of an implant material according to the invention with a matrix of hybrid material with a dense part and a porous part in concentric superposition. The compact stacking step of the microspheres of polymethyl methacrylate blowing agent was started in a mold having the desired geometry (6 mm diameter) for the porous portion of the implant. The material of the blowing agent A was polymethyl methacrylate. The spheres had a diameter of between 200 and 400 μm. The stack underwent a partial melting of the beads with a mixture of ethanol / acetone solvent and with a duration allowing the cohesion of the beads. After drying the compact stack of beads, the stack of beads is removed from the mold. We have a block of cohesive beads. This block is placed in the center of the mold having the desired geometry for the implant (diameter of 12 mm) and dimensions greater than the block of balls. The dimensions of this mold are adapted to the total dimensions of the entire dense portion and the desired porous portion. The block is attached to the bottom and the center of the mold to prevent its movement during infiltration. In a second step, the hybrid mixture of class I was poured into the mold containing the stack of beads. The volume of the pore-forming agent beads A is 20%, based on the total volume of the pore-forming agent A-biodegradable polymer P-alkoxy precursor alkoxy glass mixture. Centrifugation or infiltration under pressure or vacuum infiltration can be carried out. be used to help the hybrid mixture fill the interstices between polymethyl methacrylate microspheres. A plug, whose surface is flat, is placed in contact with the ground with the aid of a slight pressure in order to obtain a flat surface on the implant. The hybrid material was obtained by a sol-gel process. In this process, a sol containing all the alkoxy precursors of the bioactive glass is made to gel by a succession of polymerization reactions. The alkoxide precursors were in such amounts that the bioactive glass composition was 75% SiO 2 and 25% CaO, by weight, based on the total mass of the bioactive glass finally obtained. The final composition of the implant obtained was 30% bioactive glass 70% gelatin by mass, relative to the total mass of the implant material. In the case of the present example, the gelatin (the biodegradable polymer P) was added before gelation of the soil, so as to obtain a hybrid mixture.
    [0031] The implant obtained is shown in Figures 10a and 101). As can be seen in Figure 10a, the implant has a cylindrical finish with a dense portion on the outer periphery and a porous portion on the inner periphery. The implant is homogeneous and compact.
    [0032] Figure 10b clearly shows the concentric superposition of the dense portion and the porous portion obtained in the implant. Example 3 Manufacture of an Implant Material According to the Invention with a Matrix of Hybrid Material, the Porosity of Which Is Random. We began by making a mixture of balls of different diameters. The mixture consists of 25% by weight of 100-200 μm diameter beads, 25% 200-400 μm diameter beads, 25% 400-600 μm diameter beads and 25% 600-μm beads. 1000gm diameter. Then, the step of stacking the microspheres of polymethylmethacrylate pore-forming agent in a mold having the desired geometry for the implant was continued. The volume of the pore-forming agent A microspheres accounted for 50% of the total volume of the biodegradable P-precursor pore-forming agent A-polymer precursor mixture. The material of the pore-forming agent A was poly (methyl methacrylate). In a second step, the hybrid class II mixture was poured into the mold containing the stack of beads. The volume of hybrid mixture is such that all of the fused bead block is covered. Centrifugation or pressure infiltration or vacuum infiltration can be used to help the hybrid mixture fill the interstices between the polymethyl methacrylate microspheres. A plug, whose surface is flat, is placed in contact with the ground with the aid of a slight pressure in order to obtain a flat surface on the implant. The hybrid material was obtained by a sol-gel process. In this process, a sol containing all the alkoxy precursors of the bioactive glass is made to gel by a succession of polymerization reactions. The alkoxide precursors were in such amounts that the composition of the bioactive glass was 75% SiO 2 and 25% CaO, by weight, based on the total mass of the bioactive glass finally obtained. The final composition of the implant obtained was 30% bioactive glass 70% gelatin by mass, relative to the total mass of the implant material.
    [0033] In the case of the present example, the gelatin (the biodegradable polymer P) was added before gelation of the soil, so as to obtain a hybrid mixture. As can be seen in Figures 11a and 1b, this material is an implant whose pore size varies randomly within the implant.
    [0034] As seen in Figure 11a, the implant material of the invention forms a single piece of which one is dense and the other porous. FIG. 1 lb is a view taken under an electron microscope of a section of the implant obtained in this example on which the so-called "random" porous part and the dense part in planar superposition are clearly distinguished.
    [0035] Example 4 Manufacture of an Implant Material According to the Invention with a Matrix of Hybrid Material with a Dense Part and a Porous Part in Planar Superposition in Which the Biodegradable Polymer P is PDLLA
    [0036] The procedure was as in Example 1, except that the gelatin was replaced by PDLLA. The composition of the bioactive glass was 75% SiO2 - 25% CaO, by mass, relative to the total mass of the bioactive glass, and the final composition of the implant obtained was 30% bioactive glass - 70% PDLLA, by mass, by relative to the total mass of the implant material. The blowing agent A was paraffin microspheres of diameter between 600 and 1000 μm. The blowing agent spheres A represented 40% by volume, based on the total volume of the pore-forming agent A-biodegradable polymer P-alkoxy precursor precursor of the bioactive glass M. The Si solvent was tetrahydrofuran. Solvent S was cyclohexane. The implant obtained is shown in Figure 12a in which it is seen that the implant material has a size of about 2 cm with a porous portion representing more than one-third of the implant material. FIG. 12b is an electron microscope view of a section of the implant obtained in this example on which the porous portion and the planar superimposed dense portion are distinctly distinguishable.
    [0037] Example 5: Manufacture of an implant material according to the invention with a hybrid material matrix with a dense part and a planar superposition porous part in which the biodegradable polymer P is PCL.
    [0038] The procedure was as in Example 1, except that the gelatin was replaced by PCL. The composition of the bioactive glass was 75% SiO 2 - 25% CaO, by mass, relative to the total mass of the bioactive glass, and the final composition of the implant obtained was 30% bioactive glass-70% PCL, by mass, by relative to the total mass of the implant material.
    [0039] The blowing agent A was paraffin microspheres of diameter between 600 and 1000 μm. The blowing agent spheres accounted for 40% by volume, based on the total volume of the pore-forming agent A-biodegradable polymer P-precursor alkoxide mixture of bioactive glass M. The Si solvent was tetrahydrofuran.
    [0040] Solvent S was cyclohexane. As can be seen in Figures 13a and 13b, this implant material has a porous portion and a planar superposition portion. The implant obtained in this example is shown in Figures 13a and 13b. As seen in Figure 13a, the implant of the invention has a dense portion 20 of regular shape and a porous portion less compact. It generally has a frustoconical shape. Figure 13b shows the obtaining of a structure of the implant in which one part is dense and the other part is porous in planar superposition. EXAMPLE 6 Manufacture of an Implant Material According to the Invention with a Matrix of Hybrid Material Which Has a "Random" Porosity in Which the Biodegradable Polymer P Is PDLLA The procedure was as in Example 3 except that the gelatin was replaced by PDLLA. The composition of the bioactive glass was 75% SiO2 - 25% CaO, by mass, relative to the total mass of the bioactive glass, and the final composition of the implant obtained was 30% bioactive glass - 70% PDLLA, in mass, by relative to the total mass of the implant material.
    [0041] The blowing agent A was paraffin microspheres whose diameters ranged from 100-200MM, 200-400M, 400-600PD and 600-800 I / I. Each size distribution represented a fraction of 25% by mass of the total mass of the balls introduced into the mold.
    [0042] The blowing agent spheres A accounted for 30% by volume, based on the total volume of the pore-forming agent A-biodegradable polymer P-precursor alkoxide mixture of bioactive glass M. The Si solvent was tetrahydrofuran. Solvent S was cyelohexane.
    [0043] The implant obtained in this example is shown in Figures 14a and 14b. As can be seen in FIGS. 14a and 14b, this material is an implant whose pore size varies randomly within the implant, and as seen in FIG. 14a, the implant material of the implant invention forms a single piece of which one part is dense and the other porous.
    [0044] As seen in Figure 14b, the porosity of the porous portion is random in that the pore distribution is random. Example 7 Manufacture of an Implant Material According to the Invention with a Matrix of Hybrid Material, the Porosity of Which Is Random, in Which the Biodegradable Polymer P Is PCL The procedure was as in Example 3, except that the gelatin was replaced by PCL. The composition of the bioactive glass was 75% SiO 2 - 25% CaO, by mass, relative to the total mass of the bioactive glass, and the final composition of the implant obtained was 30% bioactive glass-70% PCL, by mass, by relative to the total mass of the implant material. The blowing agent A was paraffin microspheres whose diameters ranged from 100-200 micron, 200-400 micrometers, 400 micrometers, and 600-800 microns. Each size distribution represented a fraction of 25% by mass of the total mass of the balls introduced into the mold. The blowing agent spheres A represented 50% by volume, based on the total volume of the pore-forming agent A-biodegradable polymer P-alkoxy precursor precursor of the bioactive glass M. The Si solvent was tetrahydrofuran.
    [0045] Solvent S was cyclohexane. The implant obtained in this example is shown in Figures 15a and 15b. As seen in Figure 15a, the implant material of the invention forms a single piece of which one is dense and the other porous.
    [0046] As seen in Figure 15b, the porosity of the porous portion is random in that the pore distribution is random. As can be seen in Figures 15a and 15b, this material is an implant whose pore size varies randomly within the implant.
    [0047] Example 8 Manufacture of an Implant According to the Invention Using a Preform Obtained by 3D Printing The rigid impression structuring method is here implemented, an ABS preform being used as a sacrificial fingerprint to generate the porosity in the implant. In the example, the preform with a cylindrical geometry was manufactured by 3D printing and consisted of a regular mesh of ABS bars, as can be seen in FIG. 5a. The preform is first introduced into a mold, then the hybrid soil containing the biodegradable polymer and the alkoxy precursors of bioactive glass, the hybrid soil then filling the interstices of the preform. In this example, the biodegradable polymer was gelatin, and the alkoxy precursors of the bioactive glass were tetraethylorthosilicate and calcium ethoxide, mixed in such proportions that the composition of the bioactive glass obtained was 75% SiO 2 - 25% CaO. The final composition of the resulting implant was 30% bioactive glass - 70% gelatin by mass, based on the total mass of the implant material. In addition, a coupling agent, GPTMS, had been introduced into the hybrid soil in order to bind the organic and inorganic phases and thus synthesize a class hybrid. Centrifugation or pressure infiltration or vacuum infiltration can be used to help the hybrid mix to fill the free interstices of the ABS walls of the preform.
    [0048] If it is desired that the implant has a dense portion, it is necessary that the amount of hybrid soil introduced into the mold is greater than the volume left vacant in the preform (interstitial space accessible between the ABS bars of the preform) . In this case, a certain volume of hybrid soil will float above the preform; in the example, the supernatant liquid height was equal to the height of the preform. The volume of the preform made of ABS represented 30% of the total volume of the porogenic agent mixture A-biodegradable polymer P-precursors alkoxides of the bioactive glass M. After complete gelation and drying at ambient temperature, the mixture is washed several times in aqueous baths. acetone, which is a solvent for ABS, in order to completely dissolve the preform without degrading the hybrid material. As seen in FIG. 5b and FIG. 5e, the implant obtained is the exact inverse replica of the starting preform and consists of a grid of regularly spaced bioverre-gelatin hybrid walls. In the example, the walls obtained had an average thickness of 150 microns and their average spacing was 450 microns, but these characteristics can obviously be varied in a way since directly dependent on the initial mesh of the preform. Figure 5b also shows that a dense portion (2000) is successfully obtained at one end of the implant.
    [0049] Example 9 Manufacture of an Implant Material According to the Invention with a Matrix of Hybrid Material in Which the Pore Size of the Porous Portion Grows from the Base of the Implant to the Top of the Implant and Ends with a dense part in which the biodegradable polymer P is PCL.
    [0050] A compact stack of pore-forming agent spheres was made in three successive operations, so as to have a stratified distribution by sphere size interval. The volume of pore-forming spheres was split into three-thirds, depending on the size of the spheres. Starting from the compact stacking step microspheres pore-blowing agent paraffin diameter 100-200 pin, the amount introduced representing one third of the volume of the spheres. Then, over 400-600 μm diameter spheres, representing another third of the total volume of the spheres, were introduced. Finally, the last third of the total volume of the spheres is added on top, and corresponds to spheres whose diameter is greater than 600 inn. The material of the blowing agent A was paraffin. All of the pore-forming spheres introduced represented 45% by volume, based on the total volume of the pore-forming agent A-biodegradable polymer P-precursor aleoxides of bioactive glass M. In a second step, the hybrid mixture of class I bioglass / PCL d A 30/70 mass ratio was poured into the mold containing the stack of beads. The composition of the bioactive glass was 75% SiO2 - 25% CaO, by mass, relative to the total mass of the bioactive glass, and the final composition of the hybrid soil was 30% bioactive glass 70% PCL, in mass, compared to the total mass of the hybrid soil. The solvent Si was tetrahydrofuran. Solvent S was cyclohexane.
    [0051] The implant obtained in this example is shown in Figures 16a and 16b. As can be seen in FIG. 16a, the implant material of the invention has only one piece, one of which is dense and the other porous. As seen in Figure 16b, the porosity of the porous portion is gradual in that the pore distribution increases in a stratified manner to the dense portion of the implant (gradual porosity). As can be seen in Figures 16a and 16b, this material is an implant whose pore size varies gradually within the implant. Thus, the various implant materials comprising a dense portion and a porous portion are obtained by virtue of the invention. It will be clear to those skilled in the art that these materials, although manufactured in a mold to the size and shape of the bone defect to be filled or regenerated, can be machined to be adjusted even more precisely and that this step machining is also part of the process of the invention.
    权利要求:
    Claims (21)
    [0001]
    REVENDICATIONS1. An implant material made of a hybrid material, said hybrid material comprising: a biodegradable polymer P soluble in at least one SI solvent and insoluble in at least one solvent S different from the Si solvent and a bioactive glass based on SiO 2 and CaO, containing optionally P205 and / or optionally doped with strontium, characterized in that it comprises the superposition of: a porous part having more than 90% by number, of pores whose largest dimension is greater than or equal to 100 μm, and - a dense part (2, 20, 200, 2000, 20000) having more than 80% in number, of pores whose largest dimension is less than 50 i.nn.
    [0002]
    2. Implant material according to claim 1, characterized in that the volume ratio of dense part / volume of porous part is between 10/90 and 90/10. 15
    [0003]
    Implant material according to claim 1 or 2, characterized in that the pores of the porous part (1, 100, 1000, 10000) all have the same shape and dimensions.
    [0004]
    An implant material according to claim 1 or 2, characterized in that the porous portion (10) has pores (30), the largest dimension of which decreases from the base of the implant to the dense portion (20). .
    [0005]
    5. Implant material according to claim 1 or 2, characterized in that the porous portion has pores whose largest dimension increases from the base of the implant to the dense portion.
    [0006]
    Implant material according to any one of the preceding claims, characterized in that the porous part (1, 10, 100, 1000) and the dense part (2, 20, 200, 2000) are in planar superposition,
    [0007]
    Implant material according to any one of claims 1 to 5, characterized in that the porous part (10000) and the dense part (20000) are in concentric superposition. 30
    [0008]
    8. Implant material according to any one of the preceding claims, characterized in that the pores of the porous part have a spherical shape.
    [0009]
    9. Implant material according to any one of claims I to 7, characterized in that the pores of the porous part are in the form of polygons, preferably in the form of squares.
    [0010]
    10. A method of manufacturing an implant material according to any one of claims 1 to 8, characterized in that it comprises the following steps: a) selection of alkoxide precursors of a bioactive glass M based on SiO2 and CaO, optionally containing P205 and / or optionally doped with strontium, b) selecting a biodegradable polymer P that is soluble in at least one Si solvent and insoluble in at least one solvent S different from the solvent Si, c) selecting microspheres a porogenic agent A having diameters and sizes corresponding to the desired diameters and sizes of the pores in the material constituting the implant to be manufactured, this porogenic agent A being: in a polymer insoluble in the at least one solvent Siet soluble in the at least one solvent S, the at least one solvent S in which the material of the biodegradable polymer P is insoluble and the at least one solvent S in which the material of the blowing agent A is soluble in d) introducing the microspheres of the porogenic agent A into a mold having the shape and size desired for the implant, these microspheres forming a compact stack corresponding to the size and shape of the pores to be obtained for the part porous (1, 10, 100, 1000, 10000) of the implant material, and representing between 5% and 50% by volume, relative to the total volume of the pore-forming agent mixture A - biodegradable polymer P - alkoxy precursors of the bioactive glass M e) introducing the biodegradable polymer P into the alkoxy precursors of the bioactive glass M, f) introducing the mixture obtained in step e) into the mold, g) gelling the mixture contained in the mold after step 0, h) demolding the mixture obtained in step g), i) removal of the microspheres of porogen A by washing with the solvent S.
    [0011]
    11. A method of manufacturing an implant material according to any one of claims 1 to 9, characterized in that it comprises the following steps: a) selection of the alkoxy precursors of a bioactive glass M based on SiO 2 and CaO, optionally containing P205 and / or optionally doped with strontium, b) selecting a biodegradable polymer P that is soluble in at least one Siet solvent insoluble in at least one solvent S different from the solvent SI, c) manufacturing, by printing 3D, a preform (9), a polymer insoluble in the at least one solvent SI is soluble in the at least one solvent S, this preform having the final shape and size desired for the pores (3, 30) in the porous part (1, 10, 100, 1000, 10000) of the final implant and representing between 5% and 50% by volume of the total volume of the mixture preform (9) - biodegradable polymer P - precursor alkoxides of the bioactive glass M, d) introducing the preform (9) into a mold having the desired shape and size of the final implant, e) introduction of the biodegradable polymer P into the alkoxy precursors of the bioactive glass M, f) introduction of the mixture obtained in step e) into the mold, g) gelation of the contained mixture in the mold after step f), h) demolding the mixture obtained in step g), i) removing the preform (9) by washing with the solvent S.
    [0012]
    12. The method of claim 10 or 11, characterized in that steps e) and / or f) are implemented before step d).
    [0013]
    13. The method of claim 11 or 12, characterized in that steps d), e) and f) are implemented simultaneously.
    [0014]
    14. Process according to any one of claims 10 to 13, characterized in that in step d), the microsphere compact stack or the preform (9) are placed so as to touch the side walls of the mold. , leaving a free space above the stack of microspheres or preform (9), whereby the porous part (1, 10, 100, 1000) and the dense part of the implant material (2, 20 , 200, 2000) are in planar superposition. 25
    [0015]
    15. Method according to any one of claims 10 to 13, characterized in that in step d), the compact stack of microspheres or the preform (9) are placed in the center of the mold leaving a free space between the microsphere compact stack or the side walls of the preform (9) and the mold sidewalls, whereby the porous portion (10000) and the dense portion of the implant material (20000) are concentrically superimposed.
    [0016]
    16. Method according to any one of claims 10 to 15, characterized in that the biodegradable polymer P is a biodegradable polymer soluble in at least one Si solvent and insoluble in at least one solvent S selected from: - bioresorbable polysaccharides, preferably selected from dextran, hyaluronic acid, agar, chitosan, alginic acid, sodium or potassium alginate, galactomannan, carrageenan, pectin, - bioabsorbable polyesters, preferably polyvinyl alcohol or polylactic acid, biodegradable synthetic polymers, preferably a polyethylene glycol, or poly (eaprolactone), proteins, preferably gelatin or collagen, and in that the material of the blowing agent or preform (9) is a material chosen from biodegradable polymers which are insoluble in the at least one solvent S1 and soluble in the at least one solvent S, preferably chosen from C1-C4 alkyl polymethacrylates, preferably polymethyl methacrylate or butyl polymethacrylate, polyurethane, polyglycolic acid, the various forms of polylactic acid, copolymers of lactic acid-coglycolic acid, polycaprolactone , polypropylene fumarate, paraffin and naphthalene, or acrylonitrile butadiene styrene (ABS), the material of the blowing agent A or the preform (9) being different from the biodegradable polymer P.
    [0017]
    17. Method according to any one of claims 10 to 16, characterized in that the ratio by weight biodegradable polymer P / bioactive glass M is between 20/80 and 80/20 inclusive.
    [0018]
    18. Method according to any one of claims 11 to 17, characterized in that the bioactive glass M is a glass based on SiO 2 and CaO, the biodegradable polymer P is gelatin, the material of the preform (9) is ABS and solvent S is acetone. 25
    [0019]
    19. Process according to any one of claims 10 and 12 to 17, characterized in that the bioactive glass M is a glass based on SiO 2 and CaO, the biodegradable polymer P is gelatin, the porogen material A is the polymethyl methacrylate and the solvent S is acetone.
    [0020]
    20. Process according to any one of claims 10 to 19, characterized in that it further comprises, in step f), a step of introducing a coupling agent, preferably an organoalkoxysilane compound, more preferably 3-glycidoxypropyltrimethoxysilane (GPTMS), still more preferably 3-glycidoxypropyltriethoxysilane (GPTES).
    [0021]
    21. Implant made of a hybrid material for filling bone defects, bone regeneration and tissue engineering of bone, characterized in that it comprises an implant material according to any one of claims 1 to 9 or obtained by the process according to any one of claims 10 to 20.
    类似技术:
    公开号 | 公开日 | 专利标题
    EP3200842B1|2020-02-12|Hybrid material implant having variable porosity
    EP3003415B1|2018-05-16|Implant with controlled porosity comprising a matrix covered by a bioactive glass or by a hybrid material
    Miculescu et al.2017|Progress in hydroxyapatite–starch based sustainable biomaterials for biomedical bone substitution applications
    EP1778306B1|2011-06-29|Porous bioglass and preparation method thereof
    Baino et al.2019|Processing methods for making porous bioactive glass‐based scaffolds—A state‐of‐the‐art review
    Guarino et al.2012|Bio-inspired composite and cell instructive platforms for bone regeneration
    Weir et al.2006|Strong calcium phosphate cement‐chitosan‐mesh construct containing cell‐encapsulating hydrogel beads for bone tissue engineering
    WO2003101504A1|2003-12-11|Orthopaedic scaffolds for tissue engineering
    Tavakol et al.2013|Effect of laminated hydroxyapatite/gelatin nanocomposite scaffold structure on osteogenesis using unrestricted somatic stem cells in rat
    FR3051371A1|2017-11-24|PRODUCT AND PROCESS FOR THE PREPARATION OF AN INJECTABLE COMPOSITION BASED ON CHITOSAN AND BIOVERRES FOR THE REGENERATION OF BONE TISSUE
    EP2701754A1|2014-03-05|Novel multiphasic biomaterials and method for manufacturing same
    KR101419779B1|2014-07-17|Method of manufacturing bone graft materials and bone graft materials thereby
    Boccardi2017|Natural marine derived bioactive glass based scaffolds with improved functionalities
    WO2016059339A1|2016-04-21|Method for producing three-dimensional structures by moulding for tissue engineering
    FR3088550A1|2020-05-22|IMPLANT HAVING CONTROLLED POROSITY IN HYBRID MATERIAL DOPED IN NUTRIENT OSTEOINDUCTOR
    Tripathi et al.2021|Fabrication and properties of alginate/calcium phosphate hybrid beads: A comparative study
    Sobieszczyk et al.2012|Bioactive core material for porous load-bearing implants
    maheswari Krishnana2016|Silica Materials as Smart Scaffolds for Tissue Engineering
    同族专利:
    公开号 | 公开日
    AU2015326433A1|2017-05-04|
    EP3200842A1|2017-08-09|
    HUE048854T2|2020-08-28|
    PT3200842T|2020-05-07|
    EP3200842B1|2020-02-12|
    CA2962528A1|2016-04-07|
    CN106999633A|2017-08-01|
    BR112017006289A2|2017-12-12|
    JP2017529933A|2017-10-12|
    FR3026309B1|2017-11-24|
    WO2016051326A1|2016-04-07|
    ES2788703T3|2020-10-22|
    US20170348462A1|2017-12-07|
    US10549013B2|2020-02-04|
    引用文献:
    公开号 | 申请日 | 公开日 | 申请人 | 专利标题
    WO2013023064A2|2011-08-09|2013-02-14|New Jersey Institute Of Technology|Composite matrix for bone repair applications|
    US4000525A|1975-08-21|1977-01-04|The United States Of America As Represented By The Secretary Of The Navy|Ceramic prosthetic implant suitable for a knee joint plateau|
    US5981827A|1996-11-12|1999-11-09|Regents Of The University Of California|Carbon based prosthetic devices|
    WO2000076486A1|1999-06-14|2000-12-21|Imperial College Innnovations|Silver-containing, sol-gel derived bioglass compositions|
    AU8050701A|2000-07-11|2002-01-21|Imp College Innovations Ltd|Use of bioactive glass compositions to stimulate osteoblast production|
    FR2842187A1|2002-07-15|2004-01-16|Pentax Corp|BIOLOGICALLY ACTIVE GLASS BASED ON CAO-SIO2 AND CALCUIM FRITTE PHOSPHATE GLASS USING THE SAME|
    FR2918658B1|2007-07-09|2010-12-03|Centre Nat Rech Scient|BIOACTIVE LENSES DOPED IN STRONTIUM.|
    CN101628131A|2009-08-25|2010-01-20|华中科技大学|Method for preparing ultra-thin porous lamination gradient composite support of tissue engineering|
    CN102018993B|2010-12-07|2013-08-14|天津大学|Porous bracket with graded aperture distribution and manufacture method thereof|
    CN103656755A|2013-12-12|2014-03-26|华南理工大学|Preparation method of polymer-bioglass hybrid material for bone repair|US9498922B2|2014-06-26|2016-11-22|Vertera, Inc.|Apparatus and process for producing porous devices|
    US9504550B2|2014-06-26|2016-11-29|Vertera, Inc.|Porous devices and processes for producing same|
    USD815281S1|2015-06-23|2018-04-10|Vertera, Inc.|Cervical interbody fusion device|
    US10435576B2|2017-05-26|2019-10-08|Infinite Material Solutions, Llc|Water soluble polymer compositions|
    CN108578764B|2018-04-26|2020-11-27|福州大学|Rapid preparation method of bioglass/hydrogel composite material|
    US11090412B2|2018-12-21|2021-08-17|Zavation Medical Products Llc|Bone repair composition and kit|
    CN109621001A|2018-12-30|2019-04-16|山东百多安医疗器械有限公司|A kind of polyether-ether-ketone alveolar bone repairing material and personalized production method|
    法律状态:
    2015-06-29| PLFP| Fee payment|Year of fee payment: 2 |
    2016-04-01| PLSC| Publication of the preliminary search report|Effective date: 20160401 |
    2016-06-20| PLFP| Fee payment|Year of fee payment: 3 |
    2017-06-27| PLFP| Fee payment|Year of fee payment: 4 |
    2018-01-05| TQ| Partial transmission of property|Owner name: UNIVERSITE CLERMONT AUVERGNE, FR Effective date: 20171124 Owner name: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, FR Effective date: 20171124 |
    2018-06-29| PLFP| Fee payment|Year of fee payment: 5 |
    2019-07-12| PLFP| Fee payment|Year of fee payment: 6 |
    2020-09-28| PLFP| Fee payment|Year of fee payment: 7 |
    2021-09-29| PLFP| Fee payment|Year of fee payment: 8 |
    优先权:
    申请号 | 申请日 | 专利标题
    FR1459209A|FR3026309B1|2014-09-29|2014-09-29|IMPLANT WITH VARIABLE POROSITY IN A HYBRID MATERIAL|FR1459209A| FR3026309B1|2014-09-29|2014-09-29|IMPLANT WITH VARIABLE POROSITY IN A HYBRID MATERIAL|
    EP15779024.7A| EP3200842B1|2014-09-29|2015-09-28|Hybrid material implant having variable porosity|
    ES15779024T| ES2788703T3|2014-09-29|2015-09-28|Hybrid material implant that has variable porosity|
    CN201580056882.6A| CN106999633A|2014-09-29|2015-09-28|The transformable hybrid material implant of porosity|
    HUE15779024A| HUE048854T2|2014-09-29|2015-09-28|Hybrid material implant having variable porosity|
    BR112017006289A| BR112017006289A2|2014-09-29|2015-09-28|? variable porosity implant produced in hybrid material?|
    AU2015326433A| AU2015326433A1|2014-09-29|2015-09-28|Hybrid material implant having variable porosity|
    CA2962528A| CA2962528A1|2014-09-29|2015-09-28|Hybrid material implant having variable porosity|
    PCT/IB2015/057420| WO2016051326A1|2014-09-29|2015-09-28|Hybrid material implant having variable porosity|
    JP2017516695A| JP2017529933A|2014-09-29|2015-09-28|Hybrid material implant with variable porosity|
    PT157790247T| PT3200842T|2014-09-29|2015-09-28|Hybrid material implant having variable porosity|
    US15/514,724| US10549013B2|2014-09-29|2015-09-28|Hybrid material implant having variable porosity|
    [返回顶部]